Actym Appoints Steven Vicik as Chief Technical Officer
BERKELEY, CA — October 26, 2023 Actym Therapeutics, pioneering a new drug modality to treat solid tumors, announced today the appointment of Steven Vicik, PhD, as Chief Technical Officer (CTO). Dr. Steven Vicik joins the company with over 25 years of experience in pharmaceutical process and product development, manufacturing operations, as well as supply chain […]
This article is featured on another website.
HiRO and Hallym University Sacred Heart Hospital Sign Strategic MOU to Advance Drug Development
Harvest Integrated Research Organization (HiRO), a boutique global CRO, is pleased to announce the signing…
HiRO and Hallym University Sacred Heart Hospital Sign Strategic MOU to Advance Drug Development
Harvest Integrated Research Organization (HiRO), a boutique global CRO, is pleased to announce the signing…
Why Australia & New Zealand Are Smart Alternatives for Your Clinical Trial During FDA Uncertainty
Navigating the Next Few Years with Confidence 2025 has been marked by significant regulatory…
Why Australia & New Zealand Are Smart Alternatives for Your Clinical Trial During FDA Uncertainty
Navigating the Next Few Years with Confidence 2025 has been marked by significant regulatory…